Clinical Trial Update: Safety/Efficacy of Nepafenac Punctal Plug Delivery System Compared to Placebo to Control Ocular Pain/Inflammation After Cataract [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating nepafenac punctal plug delivery for ocular pain and inflammation after cataract surgery; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Inflammation Secondary to Cataract Surgery
• Postoperative Ocular Pain

Drugs mentioned

• nepafenac punctal plug delivery system (nepafenac)

Snippet

Sponsor: Mati Therapeutics Inc. | Conditions: Pain, Inflammation | Phase 2 | Status: COMPLETED | Results posted: 2021-10-12